Page 272 - Read Online
P. 272
Page 8 of 11 Vasefi et al. Vessel Plus 2020;4:24 I http://dx.doi.org/10.20517/2574-1209.2020.16
cells possess functional PDGF beta-type receptors and respond to PDGF. Proc Natl Acad Sci U S A 1991;88:8159-63.
7. Beazely MA, Lim A, Li H, Trepanier C, Chen X, et al. Platelet-derived growth factor selectively inhibits NR2B-containing N-methyl-D-
aspartate receptors in CA1 hippocampal neurons. J Biol Chem 2009;284:8054-63.
8. Yeh HJ, Ruit KG, Wang YX, Parks WC, Snider WD, et al. PDGF A-chain gene is expressed by mammalian neurons during development
and in maturity. Cell 1991;64:209-16.
9. Yeh HJ, Silos-Santiago I, Wang YX, George RJ, Snider WD, et al. Developmental expression of the platelet-derived growth factor alpha-
receptor gene in mammalian central nervous system. Proc Natl Acad Sci U S A 1993;90:1952-6.
10. Paul G, Zachrisson O, Varrone A, Almqvist P, Jerling M, et al. Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson’s
disease patients. J Clin Invest 2015;125:1339-46.
11. Papadopoulos N, Lennartsson J. The PDGF/PDGFR pathway as a drug target. Mol Aspects Med 2018;62:75-88.
12. Ishii Y, Hamashima T, Yamamoto S, Sasahara M. Pathogenetic significance and possibility as a therapeutic target of platelet derived
growth factor. Pathol Int 2017;67:235-46.
13. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 1999;81:163-221.
14. Ghafouri M, Amini S, Khalili K, Sawaya BE. HIV-1 associated dementia: symptoms and causes. Retrovirology 2006;3:28.
15. Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS
2011;25:561-75.
16. Thomas SA. Anti-HIV drug distribution to the central nervous system. Curr Pharm Des 2004;10:1313-24.
17. Lindl KA, Marks DR, Kolson DL, Jordan-Sciutto KL. HIV-associated neurocognitive disorder: pathogenesis and therapeutic
opportunities. J Neuroimmune Pharmacol 2010;5:294-309.
18. Bachis A, Mocchetti I. Brain-derived neurotrophic factor is neuroprotective against human immunodeficiency virus-1 envelope proteins.
Ann N Y Acad Sci 2005;1053:247-57.
19. Sanders VJ, Everall IP, Johnson RW, Masliah E. Fibroblast growth factor modulates HIV coreceptor CXCR4 expression by neural cells.
HNRC Group. J Neurosci Res 2000;59:671-9.
20. Malik S, Khalique H, Buch S, Seth P. A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication
in HIV/AIDS-drug abuse cases. PLoS One 2011;6:e18116.
21. Peng F, Dhillon N, Callen S, Yao H, Bokhari S, et al. Platelet-derived growth factor protects neurons against gp120-mediated toxicity. J
Neurovirol 2008;14:62-72.
22. Peng F, Dhillon NK, Yao H, Zhu X, Williams R, et al. Mechanisms of platelet-derived growth factor-mediated neuroprotection--
implications in HIV dementia. Eur J Neurosci 2008;28:1255-64.
23. Yao H, Peng F, Dhillon N, Callen S, Bokhari S, et al. Involvement of TRPC channels in CCL2-mediated neuroprotection against tat
toxicity. J Neurosci 2009;29:1657-69.
24. Yao H, Bethel-Brown C, Niu F, Yang L, Peng F, et al. Yin and Yang of PDGF-mediated signaling pathway in the context of HIV infection
and drug abuse. J Neuroimmune Pharmacol 2014;9:161-7.
25. Zhu X, Yao H, Peng F, Callen S, Buch S. PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of
extracellular glutamate and intracellular calcium. Toxicol Appl Pharmacol 2009;240:286-91.
26. Yao H, Duan M, Yang L, Buch S. Platelet-derived growth factor-BB restores human immunodeficiency virus Tat-cocaine-mediated
impairment of neurogenesis: role of TRPC1 channels. J Neurosci 2012;32:9835-47.
27. Funa K, Sasahara M. The roles of PDGF in development and during neurogenesis in the normal and diseased nervous system. J
Neuroimmune Pharmacol 2014;9:168-81.
28. Chao J, Yang L, Yao H, Buch S. Platelet-derived growth factor-BB restores HIV Tat -mediated impairment of neurogenesis: role of GSK-
3beta/beta-catenin. J Neuroimmune Pharmacol 2014;9:259-68.
29. Yang L, Chen X, Hu G, Cai Y, Liao K, et al. Mechanisms of platelet-derived growth factor-BB in restoring HIV tat-cocaine-mediated
impairment of neuronal differentiation. Mol Neurobiol 2016;53:6377-87.
30. Sato H, Ishii Y, Yamamoto S, Azuma E, Takahashi Y, et al. PDGFR-beta plays a key role in the ectopic migration of neuroblasts in
cerebral stroke. Stem Cells 2016;34:685-98.
31. Hu G, Niu F, Liao K, Periyasamy P, Sil S, et al. HIV-1 Tat-induced astrocytic extracellular vesicle miR-7 impairs synaptic architecture. J
Neuroimmune Pharmacol 2019.
32. Valenzuela CF, Xiong Z, MacDonald JF, Weiner JL, Frazier CJ, et al. Platelet-derived growth factor induces a long-term inhibition of
N-methyl-D-aspartate receptor function. J Biol Chem 1996;271:16151-9.
33. Lei S, Lu WY, Xiong ZG, Orser BA, Valenzuela CF, et al. Platelet-derived growth factor receptor-induced feed-forward inhibition of
excitatory transmission between hippocampal pyramidal neurons. J Biol Chem 1999;274:30617-23.
34. Beazely MA, Weerapura M, MacDonald JF. Abelson tyrosine kinase links PDGFbeta receptor activation to cytoskeletal regulation of
NMDA receptors in CA1 hippocampal neurons. Mol Brain 2008;1:20.
35. Zheng LS, Ishii Y, Zhao QL, Kondo T, Sasahara M. PDGF suppresses oxidative stress induced Ca2+ overload and calpain activation in
neurons. Oxid Med Cell Longev 2013;2013:367206.
36. Zheng L, Ishii Y, Tokunaga A, Hamashima T, Shen J, et al. Neuroprotective effects of PDGF against oxidative stress and the signaling
pathway involved. J Neurosci Res 2010;88:1273-84.
37. Tseng HC, Dichter MA. Platelet-derived growth factor-BB pretreatment attenuates excitotoxic death in cultured hippocampal neurons.
Neurobiol Dis 2005;19:77-83.
38. Sims KD, Straff DJ, Robinson MB. Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1